TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,764 | -77.1% | 34,900 | -31.8% | 0.00% | -75.0% |
| Q2 2023 | $1,271,808 | +5.3% | 51,200 | -36.2% | 0.01% | 0.0% |
| Q1 2023 | $1,207,712 | +74.8% | 80,300 | +37.5% | 0.01% | +71.4% |
| Q4 2022 | $690,872 | +119.4% | 58,400 | +9.8% | 0.01% | +75.0% |
| Q3 2022 | $314,944 | +121.8% | 53,200 | +257.0% | 0.00% | +300.0% |
| Q1 2022 | $142,000 | -57.7% | 14,900 | -15.8% | 0.00% | -50.0% |
| Q4 2021 | $336,000 | -25.0% | 17,700 | +90.3% | 0.00% | -50.0% |
| Q1 2021 | $448,000 | -32.7% | 9,300 | -27.3% | 0.00% | -42.9% |
| Q4 2020 | $666,000 | -13.3% | 12,800 | -55.4% | 0.01% | -22.2% |
| Q3 2020 | $768,000 | -50.2% | 28,700 | -63.8% | 0.01% | -50.0% |
| Q2 2020 | $1,543,000 | +35.0% | 79,200 | -31.8% | 0.02% | +12.5% |
| Q1 2020 | $1,143,000 | +14.0% | 116,200 | +28.5% | 0.02% | +45.5% |
| Q4 2019 | $1,003,000 | +377.6% | 90,400 | +141.7% | 0.01% | +450.0% |
| Q3 2019 | $210,000 | – | 37,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |